ATA433573A - Verfahren zur herstellung von antihamophilfaktor (ahf) - Google Patents

Verfahren zur herstellung von antihamophilfaktor (ahf)

Info

Publication number
ATA433573A
ATA433573A AT433573A AT433573A ATA433573A AT A433573 A ATA433573 A AT A433573A AT 433573 A AT433573 A AT 433573A AT 433573 A AT433573 A AT 433573A AT A433573 A ATA433573 A AT A433573A
Authority
AT
Austria
Prior art keywords
antihamophil
ahf
factor
manufacturing
manufacturing antihamophil
Prior art date
Application number
AT433573A
Other languages
English (en)
Other versions
AT344881B (de
Inventor
Lajos F Fekete
Stephen L Holst
Original Assignee
Baxter Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Laboratories Inc filed Critical Baxter Laboratories Inc
Publication of ATA433573A publication Critical patent/ATA433573A/de
Application granted granted Critical
Publication of AT344881B publication Critical patent/AT344881B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Golf Clubs (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT433573A 1972-05-17 1973-05-17 Verfahren zur herstellung von antihaemophilfaktor (ahf)-konzentrat AT344881B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00254148A US3803115A (en) 1972-05-17 1972-05-17 Stabilization of ahf using heparin

Publications (2)

Publication Number Publication Date
ATA433573A true ATA433573A (de) 1975-04-15
AT344881B AT344881B (de) 1978-08-10

Family

ID=22963114

Family Applications (1)

Application Number Title Priority Date Filing Date
AT433573A AT344881B (de) 1972-05-17 1973-05-17 Verfahren zur herstellung von antihaemophilfaktor (ahf)-konzentrat

Country Status (18)

Country Link
US (2) US3803115A (de)
JP (1) JPS596845B2 (de)
AT (1) AT344881B (de)
AU (1) AU465351B2 (de)
BE (1) BE799525A (de)
CA (1) CA1007986A (de)
CH (1) CH630804A5 (de)
DE (1) DE2324717C3 (de)
DK (1) DK136016B (de)
ES (1) ES414823A1 (de)
FR (1) FR2184898B1 (de)
GB (1) GB1372515A (de)
IL (1) IL42221A (de)
IT (1) IT1061433B (de)
NL (1) NL7306806A (de)
NO (1) NO142381C (de)
SE (1) SE430020B (de)
ZA (1) ZA733138B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates
US4022758A (en) * 1973-06-19 1977-05-10 Ab Kabi Isolation of coagulation factors I and VIII from biological material
US3973002A (en) * 1974-04-12 1976-08-03 E. R. Squibb & Sons, Inc. Antihemophilic factor
US4069216A (en) * 1975-06-16 1978-01-17 Edward Shanbrom, Inc. Simplified methods for preparation of very high purity Factor VIII concentrate
US4089944A (en) 1975-12-22 1978-05-16 Baxter Travenol Laboratories, Inc. Rapidly solubilized AHF composition and process for preparing same
JPS52125609A (en) * 1976-04-09 1977-10-21 Green Cross Corp:The Purification of agglutination factor viii
DE2624373C2 (de) * 1976-05-31 1983-02-03 Arnold Dr. 8782 Karlstadt Seufert Verfahren zur Herstellung von steril filtriertem Kryopräzipilat mit einer Anreicherung des Faktors VIII
CA1074698A (en) * 1977-12-19 1980-04-01 Gail A. Rock Method of collecting anti-hemophilic factor viii from blood and blood plasma
AT359646B (de) * 1979-04-19 1980-11-25 Immuno Ag Verfahren zur herstellung von nebenwirkungs- freien plasmafraktionen
US4210580A (en) * 1979-06-19 1980-07-01 David Amrani Process for separation and isolation of AHF and fibronectin from blood plasma
US4278594A (en) * 1979-06-19 1981-07-14 David Amrani Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma
EP0033582B1 (de) * 1980-01-18 1984-04-11 The Canadian Red Cross Society Verfahren zur Gewinnung von Faktor VIII
US4289691A (en) * 1980-01-18 1981-09-15 The Canadian Red Cross Society Method of obtaining intermediate purity factor VIII
US4305871A (en) * 1980-09-02 1981-12-15 Edward Shanbrom Method of selectively increasing yield and purity of certain cryoprecipitate proteins by heating
CA1178887A (en) * 1981-10-01 1984-12-04 Gail A. Rock Factor viii concentrates prepared from heparinized plasma by the application of a cold precipitation technique
US4397841A (en) 1982-06-28 1983-08-09 Monsanto Company Production of blood coagulation factor VIII:C
US5149787A (en) * 1984-05-22 1992-09-22 The Blood Center Research Foundation Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
GB8505882D0 (en) * 1985-03-07 1985-04-11 Central Blood Lab Authority Purification of blood coagulation factor viii
ATE73820T1 (de) * 1986-03-27 1992-04-15 Octapharma Ag Verfahren zur herstellung eines hochgereinigten antihaemophilie-faktors.
USH1509H (en) * 1989-06-09 1995-12-05 Eran; Harutyun Heparin enhanced process for separating antihemophilic factor (Factor VIII) and fibronectin from cryoprecipitate
FR2651437A1 (fr) * 1989-09-05 1991-03-08 Lille Transfusion Sanguine Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total.
FR2657884B1 (fr) * 1990-02-05 1994-09-02 Tm Innovation Procede pour la preparation du facteur viii humain et d'analogues du facteur viii.
IT1248723B (it) * 1990-06-12 1995-01-26 Scalvo S P A Processo per la purificazione del fattore viii e fattore viii ottenuto con tale processo
US5278289A (en) * 1991-11-12 1994-01-11 Johnson Alan J Antihemophilic factor stabilization
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
US7297716B2 (en) * 2000-10-23 2007-11-20 Shanbrom Technologies, Llc Enhanced production of blood components, blood cells and plasma without freezing
US6881731B1 (en) * 2000-10-23 2005-04-19 Shanbrom Technologies, Llc Enhancers for microbiological disinfection
US7411006B2 (en) * 2000-10-23 2008-08-12 Shanbrom Technologies, Llc Enhanced production of blood clotting factors and fibrin fabric
US8389687B2 (en) * 2000-10-23 2013-03-05 Shanbrom Technologies, Llc Polyvinylpyrrolidone cryoprecipitate extraction of clotting factors
MXPA03007069A (es) * 2001-02-07 2004-10-15 Shanbrom Tech Llc Acido carboxilico tal como acido citrico para desinfectar o mejorar la produccion de productos sanguineos tales como el plasma, crioprecipitado y/o plaqueta.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2867567A (en) * 1955-01-21 1959-01-06 Nat Res Dev Process of preparing anti-haemophilic globulin
DE1949314U (de) 1966-05-07 1966-11-10 Braun Fa B Bohrdraht-bereitschaftskasten.
BE713764A (de) 1967-05-01 1968-09-16 Baxter Travenol Lab
US3652530A (en) * 1967-08-28 1972-03-28 American Nat Red Cross Antihemophilic factor prepared from blood plasma using polyethylene glycol
US3560475A (en) * 1969-06-19 1971-02-02 Baxter Laboratories Inc Prothrombin complex prepared by precipitation with polyethylene glycol
US3631018A (en) * 1970-05-01 1971-12-28 Baxter Laboratories Inc Production of stable high-potency human ahf using polyethylene glycol and glycine to fractionate a cryoprecipitate of ahf concentrate
US3682881A (en) * 1970-10-02 1972-08-08 Baxter Laboratories Inc Fractionation of plasma using glycine and polyethylene glycol

Also Published As

Publication number Publication date
GB1372515A (en) 1974-10-30
AT344881B (de) 1978-08-10
US3803115A (en) 1974-04-09
AU5584973A (en) 1974-11-21
CA1007986A (en) 1977-04-05
NL7306806A (de) 1973-11-20
DK136016C (de) 1978-01-02
ZA733138B (en) 1974-03-27
FR2184898B1 (de) 1976-11-05
DE2324717B2 (de) 1980-01-03
DE2324717C3 (de) 1983-12-01
BE799525A (fr) 1973-08-31
FR2184898A1 (de) 1973-12-28
NO142381C (no) 1980-08-13
JPS596845B2 (ja) 1984-02-15
IL42221A0 (en) 1973-07-30
IT1061433B (it) 1983-02-28
SE430020B (sv) 1983-10-17
NO142381B (no) 1980-05-05
USRE29698E (en) 1978-07-11
DK136016B (da) 1977-08-01
AU465351B2 (en) 1975-09-25
JPS4956695A (de) 1974-06-01
IL42221A (en) 1977-04-29
ES414823A1 (es) 1976-02-01
CH630804A5 (de) 1982-07-15
DE2324717A1 (de) 1973-12-13

Similar Documents

Publication Publication Date Title
ATA433573A (de) Verfahren zur herstellung von antihamophilfaktor (ahf)
AT327157B (de) Verfahren zur herstellung von dimethylather
AT326670B (de) Verfahren zur herstellung von chinoxalin
AT327181B (de) Verfahren zur herstellung von neuen phenylindanestern
AT330740B (de) Verfahren zur herstellung von neuensulfonamidodiphenylathern
DD108102A5 (de) Verfahren zur herstellung von pfropfcopolymeren
AT322838B (de) Verfahren zur herstellung von poly-alfa-olefinen
AT325208B (de) Verfahren zur herstellung von gammaglobulin
AT338778B (de) Verfahren zur herstellung von furanderivaten
AT329552B (de) Verfahren zur herstellung von indolderivaten
DD104533A5 (de) Verfahren zur herstellung von olefintetrapolymeren
AT335456B (de) Verfahren zur herstellung von cyanpyridinen
AT321925B (de) Verfahren zur herstellung von phthalazon
AT322105B (de) Verfahren zur herstellung von desacetoxycephalosporinderivaten
AT334879B (de) Verfahren zur herstellung von neuen arylathern
AT332380B (de) Verfahren zur herstellung von chlorameisensaurearylestern
ATA504673A (de) Verfahren zur herstellung von ueberzuegen
AT330379B (de) Verfahren zur herstellung von cis-zearalenen
AT325576B (de) Verfahren zur herstellung von kryolith
AT338229B (de) Verfahren zur herstellung von neuen aldehydolactonen
ATA611773A (de) Verfahren zur herstellung von ketoalkylxanthinen
ATA527672A (de) Verfahren zur herstellung von konjakumannan
AT331833B (de) Verfahren zur herstellung von gleisen
ATA578072A (de) Verfahren zur herstellung von bauelementen
AT340364B (de) Verfahren zur herstellung von diamanten

Legal Events

Date Code Title Description
EFA Change in the company name
ELA Expired due to lapse of time